2. Search Result
Search Result
Results for "

Didanosine

" in MedChemExpress (MCE) Product Catalog:

7

Inhibitors & Agonists

2

Isotope-Labeled Compounds

1

Oligonucleotides

Art. -Nr. Produktname Target Forschungsgebiete Chemical Structure
  • HY-B0249
    Didanosine
    1 Publications Verification

    2',3'-Dideoxyinosine; ddI

    		 HIV Reverse Transcriptase Infection Neurological Disease Inflammation/Immunology
    Didanosine (2',3'-Dideoxyinosine; ddI) is a a potent and orally active dideoxynucleoside analogue, and also is a potent nucleoside reverse transcriptase inhibitor. Didanosine shows antiretroviral activity for HIV .
    Didanosine
  • HY-B0249S
    Didanosine-d2

    		Isotope-Labeled Compounds HIV Reverse Transcriptase Infection
    Didanosine-d2 is the deuterium labeled Didanosine. Didanosine (Videx) is a reverse transcriptase inhibitor with an IC50 of 0.49 μM.
    Didanosine-d2
  • HY-B0249R
    Didanosine (Standard)

    2',3'-Dideoxyinosine (Standard); ddI (Standard)

    		 Reference Standards HIV Reverse Transcriptase Infection
    Didanosine (Standard) is the analytical standard of Didanosine. This product is intended for research and analytical applications. Didanosine (2',3'-Dideoxyinosine; ddI) is a a potent and orally active dideoxynucleoside analogue, and also is a potent nucleoside reverse transcriptase inhibitor. Didanosine shows antiretroviral activity for HIV .
    Didanosine (Standard)
  • HY-105232
    AZT-P-ddI

    IVX-E-59

    		 HIV Infection
    AZT-P-ddI is an antiviral heterodimer composed of Zidovudine (AZT) (HY-17413) and Didanosine (ddI) (HY-B0249). AZT-P-ddI shows inhibitory effect against HIV-1 with an EC50 of 0.14 nM. AZT-P-ddI can be used for the research of infection .
    AZT-P-ddI
  • HY-W765997
    Didanosine-13C2,15N

    2',3'-Dideoxyinosine-13C2,15N; ddI-13C2,15N

    		 Isotope-Labeled Compounds Reverse Transcriptase HIV Infection
    Didanosine- 13C2, 15N (2',3'-Dideoxyinosine- 13C2, 15N; ddI- 13C2, 15N) is the 13C- and 15N-labeled labeled Didanosine (HY-B0249). Didanosine (2',3'-Dideoxyinosine; ddI) is a a potent and orally active dideoxynucleoside analogue, and also is a potent nucleoside reverse transcriptase inhibitor. Didanosine shows antiretroviral activity for HIV .
    Didanosine-13C2,15N
  • HY-105097
    Atevirdine mesylate

    U 87201E mesylate

    		 HIV Reverse Transcriptase Inflammation/Immunology
    Atevirdine (U 87201E) mesylate is a nonnucleoside reverse transcriptase (NNRT) inhibitor. Atevirdine mesylate can inhibit human immunodeficiency virus type 1 (HIV-1) with an IC50 of 0.06-1.6 μM. Atevirdine mesylate shows highly synergistic effects against Zidovudine/Didanosine-resistant clinical isolates of HIV-1 companied with Zidovudine (HY-17413)/Didanosine (Hy-B0249). Atevirdine mesylate can be used for the research of AIDS .
    Atevirdine mesylate
  • HY-122268
    QYL-685

    		HIV Infection
    QYL-685 is a Z-methenylcyclopropane nucleoside analog containing 2,6-diaminopurine, which has strong antiviral activity against HIV-1. QYL-685 showed activity against Zidovudine (HY-17413) resistant and Didanosine (HY-B0249) resistant HIV-1 infected clones in vitro. QYL-685 can be used for the study of HIV-1 infection .
    QYL-685

Online-Anfrage

Your information is safe with us. * Required Fields.

Anrede

  

Country or Region *

Name des Antragstellers *

 

Name der Organisation *

Department *

     

E-Mail-Addresse *

 

Produktname *

Art. -Nr.

  

Requested quantity *

Telefonnummer *

     

Bemerkungen

Online-Anfrage

Inquiry Information

Produktname:
Art. -Nr.:
Menge:
MCE Japan Authorized Agent: